BlackRock Investment Management, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$845,000
-33.7%
277,184
+0.7%
0.00%
-50.0%
Q3 2016$1,275,000
-20.2%
275,389
-0.2%
0.00%0.0%
Q2 2016$1,598,000
+12.4%
275,923
+17.4%
0.00%0.0%
Q1 2016$1,422,000
-32.7%
235,000
+1.5%
0.00%
-33.3%
Q4 2015$2,113,000
+62.2%
231,421
+0.2%
0.00%
+50.0%
Q3 2015$1,303,000
-49.9%
231,058
-1.4%
0.00%
-33.3%
Q2 2015$2,600,000
-11.9%
234,428
+24.6%
0.00%
-25.0%
Q1 2015$2,950,000
+4.9%
188,129
+1.7%
0.00%0.0%
Q4 2014$2,813,000
+39.4%
184,953
-1.2%
0.00%
+33.3%
Q3 2014$2,018,000
-28.9%
187,138
+0.7%
0.00%
-25.0%
Q2 2014$2,839,000
-14.6%
185,892
+1.1%
0.00%
-20.0%
Q1 2014$3,325,000
+43.5%
183,894
+10.2%
0.01%
+66.7%
Q4 2013$2,317,000
+30.8%
166,822
-1.2%
0.00%0.0%
Q3 2013$1,771,000
+57.7%
168,872
+17.4%
0.00%
+50.0%
Q2 2013$1,123,000143,8350.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders